Tested Applications
| Positive WB detected in | HT-29 cells, U2OS cells, Caco-2 cells, PC-3 cells |
| Positive IP detected in | HT-29 cells |
| Positive IHC detected in | human pancreas cancer tissue, mouse spleen tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HT-29 cells |
| Positive FC (Intra) detected in | HT-29 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11685-1-AP targets PLEK2 in WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2297 Product name: Recombinant human PLEK2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 90-353 aa of BC001226 Sequence: EERDAWAFEITGAIHAGQPGKVQQLHSLRNSFKLPPHISLHRIVDKMHDSNTGIRSSPNMEQGSTYKKTFLGSSLVDWLISNSFTASRLEAVTLASMLMEENFLRPVGVRSMGAIRSGDLAEQFLDDSTALYTFAESYKKKISPKEEISLSTVELSGTVVKQGYLAKQGHKRKNWKVRRFVLRKDPAFLHYYDPSKEENRPVGGFSLRGSLVSALEDNGVPTGVKGNVQGNLFKVITKDDTHYYIQASSKAERAEWIEAIKKLT Predict reactive species |
| Full Name | pleckstrin 2 |
| Calculated Molecular Weight | 353 aa, 40 kDa |
| Observed Molecular Weight | 38-40 kDa |
| GenBank Accession Number | BC001226 |
| Gene Symbol | PLEK2 |
| Gene ID (NCBI) | 26499 |
| RRID | AB_2252364 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NYT0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PLEK2 belongs to the Pleckstrin homology domain family and is a 40-kDa protein containing the prototypic PH domains at its amino and carboxyl termini(PMID: 10419454). PLEK2 associates with membrane-bound phosphatidylinositols generated by phosphatidylinositol 3-kinase. PLEK2 interacts with the actin cytoskeleton to induce cell spreading.
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for PLEK2 antibody 11685-1-AP | Download protocol |
| IF protocol for PLEK2 antibody 11685-1-AP | Download protocol |
| IHC protocol for PLEK2 antibody 11685-1-AP | Download protocol |
| IP protocol for PLEK2 antibody 11685-1-AP | Download protocol |
| WB protocol for PLEK2 antibody 11685-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
PLEK2 (Pleckstrin-2) antibody (Cat# 11685-1-AP) has 22 citations across journals including Journal of Clinical Investigation, Journal of Experimental & Clinical Cancer Research, Cancer Letters, Cell Death & Disease, Haematologica, Communications Biology, International Journal of Cancer, American Journal of Pathology, Cell Signaling, Molecular Carcinogenesis, and others. Research fields span oncology (lung, gastric, pancreatic, breast, esophageal, and head and neck cancers), myeloproliferative neoplasms, erythropoiesis, and placental biology.
| Species | Application | Title |
|---|---|---|
Cancer Commun (Lond) PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop
| ||
J Clin Invest Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
| ||
J Exp Clin Cancer Res PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. | ||
J Clin Invest Targeting pleckstrin-2-Akt signaling reduces proliferation in myeloproliferative neoplasm models | ||
Mol Biomed Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer
| ||
Cell Death Dis TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
|

















